Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control
June 3, 2020
SonaCare Medical announces new study results that shows focal ablative salvage therapy after radio-recurrent prostate cancer is safe and provides good cancer control over 6 years.